Researchers at the National Cancer Institute (NCI) are conducting a clinical trial to study new imaging techniques for those with HCC. Pictures (Images) are taken with a positron emission tomography (PET) using a new investigational imaging radiotracer, 18 F-DCFPyL. Our research study focus is to see if this tracer will improve images taken of your liver to identify HCC tumors earlier in the disease process. We will also determine if we can see differences between treated tumors and the development of new tumors.
YOU MAY BE ELIGIBLE IF YOU ARE:
- 18 years of age or older
- Diagnosed with suspected HCC tumor
- Able to receive current standard therapy
IF YOU JOIN THE STUDY YOU WILL HAVE:
- A medical history, physical exam, and blood tests for screening
- Body PET with ‘tracer’/ computed tomography (CT) scans
- A tumor biopsy to confirm your HCC diagnosis
- Study-related tests will be provided at no cost to you
- You may be reimbursed for travel and lodging cost
The NIH Clinical Center, America’s Research Hospital located in Bethesda, MD Metro red line (Medical Center stop).
For more information call us at:
800-411-1222
TTY users dial 7-1-1
Email: ccopr@nih.gov
Refer to study 000080-C
Or go online:
https://go.usa.gov/xuh92
PI: Freddy E. Escorcia, MD
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)